3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
2
Colonic Neoplasms
1
Interventions
Cetuximab
5
Bevacizumab
4
pembrolizumab
3
Leucovorin
3
Irinotecan
3
Fluorouracil
3
trifluridine tipiracil drug combination
2
trastuzumab deruxtecan
2
larotrectinib
2
encorafenib
2
binimetinib
2
Trastuzumab
2
Oxaliplatin
2
Nivolumab
2
HMPL-013
2
Afatinib
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sotorasib
1
sapanisertib
1
relatlimab
1
regorafenib
1
pralsetinib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has announcements
×
Colorectal Neoplasms
×
HMPL-013
×
Clear all
NCT04322539
2025-04-04
FRESCO-2
Hutchmed
Phase 3
Completed
691 enrolled
26 charts
1 FDA
NCT02314819
2020-02-17
FRESCO
Hutchmed
Phase 3
Completed
416 enrolled
1 FDA